Recital 3, Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 3×

Whereas effective and harmonised protection throughout the Member States is essential in order to maintain and encourage investment in the field of biotechnology;

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    That conclusion is supported by the object and the aim of the Directive. It follows from recitals 3 and 5 to 7 in the preamble to the Directive that it seeks, by a harmonisation of the rules for the legal protection of biotechnological …

    18 Oct 2011 · 62010CJ0034

  • Judgment of the Court (Grand Chamber) of 6 July 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    In order to answer the second question, it is appropriate to note that, in recitals 3 and 5 to 7 in the preamble to the Directive, the Community legislature states that: effective and harmonised protection throughout the Member States is …

    6 Jul 2010 · 62008CJ0428

  • Judgment of the Court (Grand Chamber), 18 December 2014. International Stem Cell Corporation v Comptroller General of Patents, Designs and TDecision

    Recitals 1 to 3, 16, 37 to 39, 42 and 43 in the preamble to Directive 98/44 are worded as follows: ‘(1) Whereas biotechnology and genetic engineering are playing an increasingly important role in a broad range of industries and the …

    18 Dec 2014 · 62013CJ0364